In 2021, as was the case in 2020, many analgesics categories are seeing volume sales increasing more than normal due to COVID-19. The outbreak of the pandemic in 2020 led to panic, and consumers increased their demand and were buying and stockpiling various consumer goods.
In Tunisia, online sales have been growing for the majority of consumer goods, with many categories witnessing a strong shift towards e-commerce. However, this is not the case for consumer health, and analgesics in particular.
Sanofi-Aventis Pharma Tunisie continues to lead analgesics in 2021. The company is supported by a solid pricing strategy in addition to wide availability of its offerings.
Analgesics continues to witness positive value sales growth in 2021 and growth will remain healthy over the forecast period, with the category expected to start to recover from the impact of COVID-19 by 2022. Sales will continue to witness healthy growth thanks to Tunisian consumers’ preference for self-medication.
The third wave of COVID-19 in January 2021 helped analgesics to see increasing demand again, and it was obvious that consumers rely on analgesics, given the delay of the public vaccination in Tunisia. During the forecast period, the slowly progressing level of vaccinated population is likely to lower the fear of becoming infected, and for this reason demand for analgesics will remain stable, with no major surprises anticipated.
The majority of analgesics manufactured locally in Tunisia are owned by international laboratories, mainly from France. These global brands are widely available in the country, benefiting from top-of-mind awareness among consumers, which has encouraged local producers to increase their production.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Tunisia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Tunisia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!